Skip to content

AgelessRx

5 viewers · 30d

Total raised

$5.5M

+$5.5M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $5.5M
ROUNDS
1
INVESTORS
32
FOUNDED
N/A
HQ
Ann Arbor, MI
SECTOR
Biotechnology
EMPLOYEES
N/A
30D VIEWERS
5

AI overview

Updated

AgelessRx is a direct-to-consumer telehealth company founded in 2020 that provides science-backed longevity treatments aimed at enhancing healthspan. The platform offers personalized protocols, prescription therapies, diagnostics, and supplements to address the root causes of aging. It operates on a subscription-based membership model, connecting users with licensed clinicians to facilitate preventive care.

What sets it apart

The company positions itself as a pioneering, data-driven longevity platform that offers clinician-guided protocols that are continuously updated with patient data. A key differentiator is its operation of large, decentralized clinical trials, such as the PEARL trial for Rapamycin, which allows for real-world evidence gathering on a large scale.

Funding history

1 round
EquityJan 12, 2026
Form D
+$5.5M$5.5M total

Latest SEC filings

via EDGAR · CIK 0002109810
Form D · Jan 12, 2026View on EDGAR

Products

1 tracked

Personalized Longevity Telehealth Platform

Telehealth Platform

The core offering is a telehealth platform providing access to U.S.-licensed providers who guide patients through personalized longevity treatments. The service focuses on preventive care through science-backed protocols, prescription therapies like Metformin and NAD+, advanced diagnostics, and supplements addressing key areas such as metabolic health, sleep, and cognitive function.

  • Access to over 30 diagnostics and therapeutics
  • Protocols vetted by a Stanford PhD-led science team
  • Personalized treatment plans with ongoing updates based on patient data
  • Reported 82.7% of patients see improvements by their first check-in